Novel Targeted Radiotherapy in Pediatric Patients With Inoperable Relapsed or Refractory HGG

NCT05610891 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

High-Grade Glioma

Interventions

DRUG: CLR 131

Sponsor

Cellectar Biosciences, Inc.

Collaborators

[object Object]